Daniel Ngai

772 total citations
4 papers, 201 citations indexed

About

Daniel Ngai is a scholar working on Oncology, Neurology and Biotechnology. According to data from OpenAlex, Daniel Ngai has authored 4 papers receiving a total of 201 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 1 paper in Neurology and 1 paper in Biotechnology. Recurrent topics in Daniel Ngai's work include CAR-T cell therapy research (4 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Neuroblastoma Research and Treatments (1 paper). Daniel Ngai is often cited by papers focused on CAR-T cell therapy research (4 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Neuroblastoma Research and Treatments (1 paper). Daniel Ngai collaborates with scholars based in United States. Daniel Ngai's co-authors include Erin McGee, Prasad S. Adusumilli, Roisin E. O’Cearbhaill, Michel Sadelain, John Pineda, Claudia Diamonte, Shanu Modi, David R. Jones, A. Vincent and Marjorie G. Zauderer and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Translational research.

In The Last Decade

Daniel Ngai

4 papers receiving 198 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Ngai United States	4	161	71	54	51	48	4	201
Erin McGee United States	6	172 1.1×	72 1.0×	53 1.0×	61 1.2×	63 1.3×	6	226
Jiang Lv China	6	162 1.0×	90 1.3×	41 0.8×	34 0.7×	37 0.8×	8	225
Waseem Cheema United States	3	81 0.5×	45 0.6×	29 0.5×	27 0.5×	25 0.5×	6	112
Shon Green United States	5	136 0.8×	60 0.8×	33 0.6×	30 0.6×	20 0.4×	7	184
John Pineda United States	6	174 1.1×	50 0.7×	28 0.5×	51 1.0×	68 1.4×	11	206
Leticia Bosshard‐Carter United Kingdom	5	151 0.9×	55 0.8×	12 0.2×	64 1.3×	40 0.8×	5	162
Yvonne S.L. Mak United States	4	114 0.7×	57 0.8×	19 0.4×	26 0.5×	23 0.5×	5	195
Youguo Long China	8	209 1.3×	125 1.8×	13 0.2×	46 0.9×	53 1.1×	10	243
Yaara Ohayon United States	4	309 1.9×	231 3.3×	16 0.3×	31 0.6×	54 1.1×	4	335
Cheryl A. Cox United States	9	229 1.4×	177 2.5×	26 0.5×	22 0.4×	47 1.0×	16	287

Countries citing papers authored by Daniel Ngai

Since Specialization

Citations

This map shows the geographic impact of Daniel Ngai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Ngai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Ngai more than expected).

Fields of papers citing papers by Daniel Ngai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Ngai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Ngai. The network helps show where Daniel Ngai may publish in the future.

Co-authorship network of co-authors of Daniel Ngai

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Ngai. A scholar is included among the top collaborators of Daniel Ngai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Ngai. Daniel Ngai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Adusumilli, Prasad S., Marjorie G. Zauderer, Valerie W. Rusch, et al.. (2019). Abstract CT036: A phase I clinical trial of malignant pleural disease treated with regionally delivered autologous mesothelin-targeted CAR T cells: Safety and efficacy. Cancer Research. 79(13_Supplement). CT036–CT036. 44 indexed citations

2.

Adusumilli, Prasad S., Marjorie G. Zauderer, Valerie W. Rusch, et al.. (2019). Abstract CT036: A phase I clinical trial of malignant pleural disease treated with regionally delivered autologous mesothelin-targeted CAR T cells: Safety and efficacy. Clinical Trials. CT036–CT036. 8 indexed citations

3.

Adusumilli, Prasad S., Marjorie G. Zauderer, Valerie W. Rusch, et al.. (2019). Regional delivery of mesothelin-targeted CAR T cells for pleural cancers: Safety and preliminary efficacy in combination with anti-PD-1 agent.. Journal of Clinical Oncology. 37(15_suppl). 2511–2511. 74 indexed citations

4.

McGee, Erin, et al.. (2017). CAR T-cell therapy for lung cancer and malignant pleural mesothelioma. Translational research. 187. 1–10. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact